MECHANISMS OF DIABETIC COMPLICATIONS

被引:1867
作者
Forbes, Josephine M.
Cooper, Mark E. [1 ]
机构
[1] Baker IDI Heart & Diabet Inst, Diabet Div, Melbourne, Vic, Australia
关键词
GLYCATION END-PRODUCTS; PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; ENDOPLASMIC-RETICULUM-STRESS; NITRIC-OXIDE SYNTHASE; INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GLOMERULAR-FILTRATION-RATE;
D O I
10.1152/physrev.00045.2011
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Forbes JM, Cooper ME. Mechanisms of Diabetic Complications. Physiol Rev 93: 137-188, 2013; doi:10.1152/physrev.00045.2011.-It is increasingly apparent that not only is a cure for the current worldwide diabetes epidemic required, but also for its major complications, affecting both small and large blood vessels. These complications occur in the majority of individuals with both type 1 and type 2 diabetes. Among the most prevalent microvascular complications are kidney disease, blindness, and amputations, with current therapies only slowing disease progression. Impaired kidney function, exhibited as a reduced glomerular filtration rate, is also a major risk factor for macrovascular complications, such as heart attacks and strokes. There have been a large number of new therapies tested in clinical trials for diabetic complications, with, in general, rather disappointing results. Indeed, it remains to be fully defined as to which pathways in diabetic complications are essentially protective rather than pathological, in terms of their effects on the underlying disease process. Furthermore, seemingly independent pathways are also showing significant interactions with each other to exacerbate pathology. Interestingly, some of these pathways may not only play key roles in complications but also in the development of diabetes per se. This review aims to comprehensively discuss the well validated, as well as putative mechanisms involved in the development of diabetic complications. In addition, new fields of research, which warrant further investigation as potential therapeutic targets of the future, will be highlighted.
引用
收藏
页码:137 / 188
页数:52
相关论文
共 695 条
  • [1] Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the UK
    Abbott, Caroline A.
    Malik, Rayaz A.
    van Ross, Ernest R. E.
    Kulkarni, Jai
    Boulton, Andrew J. M.
    [J]. DIABETES CARE, 2011, 34 (10) : 2220 - 2224
  • [2] Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats
    Abdelrahman, Aly M.
    Al Suleimani, Yousuf M.
    [J]. ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (12) : 1584 - 1589
  • [3] Bioenergetic characterization of mouse podocytes
    Abe, Yoshifusa
    Sakairi, Toru
    Kajiyama, Hiroshi
    Shrivastav, Shashi
    Beeson, Craig
    Kopp, Jeffrey B.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2010, 299 (02): : C464 - C476
  • [4] Diabetes, Sexual Dysfunction and Therapeutic Exercise: A 20 Year Review
    Adeniyi, Ade F.
    Adeleye, Jokotade O.
    Adeniyi, Celia Y.
    [J]. CURRENT DIABETES REVIEWS, 2010, 6 (04) : 201 - 206
  • [5] Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
    Adler, Sharon G.
    Schwartz, Sherwyn
    Williams, Mark E.
    Arauz-Pacheco, Carlos
    Bolton, Warren K.
    Lee, Tyson
    Li, Dongxia
    Neff, Thomas B.
    Urquilla, Pedro R.
    Sewell, K. Lea
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (08): : 1420 - 1428
  • [6] Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
    Advani, Andrew
    Kelly, Darren J.
    Advani, Suzanne L.
    Cox, Alison J.
    Thai, Kerri
    Zhang, Yuan
    White, Kathryn E.
    Gow, Renae M.
    Marshall, Sally M.
    Steer, Brent M.
    Marsden, Philip A.
    Rakoczy, P. Elizabeth
    Gilbert, Richard E.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (36) : 14448 - 14453
  • [7] Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent Mechanism
    Advani, Andrew
    Huang, Qingling
    Thai, Kerri
    Advani, Suzanne L.
    White, Kathryn E.
    Kelly, Darren J.
    Yuen, Darren A.
    Connelly, Kim A.
    Marsden, Philip A.
    Gilbert, Richard E.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2011, 178 (05) : 2205 - 2214
  • [8] A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy
    Agarwal, R
    Saha, C
    Battiwala, M
    Vasavada, N
    Curley, T
    Chase, SD
    Sachs, N
    Semret, MH
    [J]. KIDNEY INTERNATIONAL, 2005, 68 (01) : 285 - 292
  • [9] Ahmed AM, 2002, SAUDI MED J, V23, P373
  • [10] Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
    Aiello, LP
    Bursell, SE
    Clermont, A
    Duh, E
    Ishii, H
    Takagi, C
    Mori, F
    Ciulla, TA
    Ways, K
    Jirousek, M
    Smith, LEH
    King, GL
    [J]. DIABETES, 1997, 46 (09) : 1473 - 1480